Recital 4, Regulation (EU) 2023/1764

In forcesince 12 Sep 2023

On 17 October 2022, the Agency submitted to the Commission its opinion [ECHA opinion of 14 June 2022 on the Union authorisation of ‘Oxy’Pharm H2O2’ (ECHA/BPC/358/2022), https://echa.europa.eu/opinions-on-union-authorisation.], including the draft summary of the biocidal product characteristics (‘SPC’) of ‘Oxy’Pharm H2O2’ and the final assessment report on the biocidal product family in accordance with Article 44(3) of Regulation (EU) No 528/2012.